M&A Deal Summary |
|
---|---|
Date | 2017-08-15 |
Target | Omega Bittner |
Sector | Life Science |
Buyer(s) | Alvogen |
Sellers(s) | Perrigo Company |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2009 |
Sector | Life Science |
Employees | 2,000 |
Alvogen is a multinational pharmaceuticals company focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology, and gastroenterology. Alvogen has commercial operations in over 30 countries across North America, Central and Eastern Europe, and the Asia Pacific. Alvogen was founded in 2009 and is based in Morristown, New Jersey.
DEAL STATS | # |
---|---|
Overall | 7 of 8 |
Sector (Life Science) | 7 of 8 |
Type (Divestiture) | 3 of 4 |
Country (Russia) | 2 of 2 |
Year (2017) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-03-03 |
County Line Pharmaceuticals
Brookfield, Wisconsin, United States County Line Pharmaceuticals LLC is a specialty generic pharmaceutical company focusing on growth through the acquisition or in-licensing of under-appreciated generic assets, marketing of Authorized Generic products and the development of specialty generic products. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-10-25 |
Alvogen CEE
Poland Alvogen CEE markets over 200 generic and over-the-counter products across multiple therapeutic areas, consisting of highly recognized brands like Lactacyd, Persen, EuBiotic and many more with leading market positions in 14 key markets across CEE including; Russia, Romania, Bulgaria, Hungary, Poland and Balkan markets. |
Sell | - |
Category | Company |
---|---|
Founded | 1887 |
Sector | Life Science |
Employees | 9,140 |
Revenue | 4.7B USD (2023) |
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo Company was founded in 1887 and is based in Dublin, Ireland.
DEAL STATS | # |
---|---|
Overall | 5 of 9 |
Sector (Life Science) | 4 of 7 |
Type (Divestiture) | 5 of 9 |
Country (Russia) | 1 of 1 |
Year (2017) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-08-11 |
Wavelength Pharmaceuticals
Petah Tikva, Israel Wavelength Pharmaceuticals is a developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel and supporting functions in the U.S. and India. The Business has a global customer base and a broad array of products that leverage its specialized manufacturing capabilities and core competency in complex chemistries. Wavelength Pharmaceuticals is based in Petah Tikva, Israel. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-05-09 |
Ranir
Grand Rapids, Michigan, United States Ranir LLC is a manufacturer of private label consumer oral and personal care products, including power and manual toothbrushes, teeth whiteners, dental floss and flossers, interdental devices, travel accessories and more. Ranir LLC was founded in 1979 and is based in Grand Rapids, Michigan. |
Buy | $750M |